Iman A. Y. Ghannam - Concepedia

Author

Iman A. Y. Ghannam

National Research Centre ORCID

Also Known As

Ghannam, Iman A. Y., Iman A. Y. Ghannam, Iman A.Y. Ghannam, Iman Ahmed Youssef Ghannam

Publications

313

Citations

H-Index

Concepts

All Affiliations

National Research Centre Cairo University Istituto di Scienze e Tecnologie Chimiche "Giulio Natta"University of Lincoln

About

Iman A. Y. Ghannam is an author at National Research Centre specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	189
2	Biochemistry	3	3	87
3	Natural Sciences	2	2	93
4	Chemistry	1	1	51
5	Diabetes	1	1	23

Iman A. Y. Ghannam

Publications

269

Citations

H-Index

Page 1

	Year	Citations
Synthesis, molecular docking study and antitumor activity of novel 2-phenylindole derivatives Sally S. El‐Nakkady, Mona M. Hanna, Hanaa M. F. Roaiah, European Journal of Medicinal Chemistry Combinatorial ChemistryMedicinal ChemistryAntitumor ActivityNovel 2-Phenylindole DerivativesNatural Sciences	2011	51
Design, synthesis and anticancer activity of novel 2-arylbenzimidazole/2-thiopyrimidines and 2-thioquinazolin-4(3H)-ones conjugates as targeted RAF and VEGFR-2 kinases inhibitors Islam H. Ali, Heba T. Abdel‐Mohsen, Marwa M. Mounier, Bioorganic Chemistry Novel 2-Arylbenzimidazole/2-thiopyrimidinesMedicinal ChemistryVegfr-2 Kinases InhibitorsMedicinePharmacological Agent	2022	51
Novel 2-arylbenzothiazole DNA gyrase inhibitors: Synthesis, antimicrobial evaluation, QSAR and molecular docking studies Iman A. Y. Ghannam, Eman A. Abd El‐Meguid, Islam H. Ali, Bioorganic Chemistry Molecular Docking StudiesMedicinal ChemistryBiochemistryMedicineAntimicrobial Evaluation	2019	42
Design, synthesis, and molecular docking of novel indole scaffold‐based VEGFR‐2 inhibitors as targeted anticancer agents Hanaa M. F. Roaiah, Iman A. Y. Ghannam, Islam H. Ali, Archiv der Pharmazie	2018	30
Novel thiazolidin-4-one benzenesulfonamide hybrids as PPARγ agonists: Design, synthesis and in vivo anti-diabetic evaluation Islam H. Ali, Rasha M. Hassan, Ahmed M. El Kerdawy, European Journal of Medicinal Chemistry Pharmaceutical SciencePparγ AgonistsBiochemistryMedicineDiabetes	2024	23
Discovery of 4-benzyloxy and 4-(2-phenylethoxy) chalcone fibrate hybrids as novel PPARα agonists with anti-hyperlipidemic and antioxidant activities: Design, synthesis and in vitro/in vivo biological evaluation Rasha M. Hassan, Mona E. Aboutabl, Manuela Bozzi, Bioorganic Chemistry Pharmaceutical ScienceBiochemistryChalcone Fibrate HybridsMedicinePharmacological Agent	2021	22
Design and synthesis of novel quinazolinone‐based fibrates as PPARα agonists with antihyperlipidemic activity Rasha M. Hassan, Islam H. Ali, Mohammed S. Abdel‐Maksoud, Archiv der Pharmazie	2021	19
Novel 2‐oxo‐2‐phenylethoxy and benzyloxy diaryl urea hybrids as VEGFR‐2 inhibitors: Design, synthesis, and anticancer evaluation Iman A. Y. Ghannam, Ahmed M. El Kerdawy, Marwa M. Mounier, Archiv der Pharmazie	2022	18
Novel benzenesulfonamides as dual VEGFR2/FGFR1 inhibitors targeting breast cancer: Design, synthesis, anticancer activity and in silico studies Rasha M. Hassan, Islam H. Ali, Ahmed M. El Kerdawy, Bioorganic Chemistry	2024	13

Page 1